Research Article
The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Figure 1
The design of HFD/low-dose STZ model of DM2 and the treatment of rats with intranasally administered serotonin.